US Stock MarketDetailed Quotes

PMV Pharmaceuticals (PMVP)

Watchlist
  • 1.120
  • -0.020-1.75%
Trading Jan 23 10:47 ET
59.60MMarket Cap-0.70P/E (TTM)

PMV Pharmaceuticals (PMVP) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-17.70%-19.82M
-1,045.31%-18.3M
-12.86%-18.27M
7.86%-51.28M
-37.87%-16.66M
-7.54%-16.84M
87.61%-1.6M
-7.81%-16.18M
12.71%-55.66M
21.14%-12.09M
Net income from continuing operations
-9.53%-21.06M
-1,648.56%-21.21M
-14.18%-17.44M
14.87%-58.71M
-45.98%-23M
-15.54%-19.23M
93.04%-1.21M
20.17%-15.27M
5.94%-68.96M
18.55%-15.76M
Operating gains losses
---1K
--34K
--4K
--4.67M
--4.67M
----
----
----
----
----
Depreciation and amortization
-91.64%31K
-91.40%32K
-89.78%37K
-8.99%1.14M
-89.14%39K
3.63%371K
0.81%372K
111.70%362K
299.05%1.26M
378.67%359K
Other non cash items
98.73%-2K
84.31%-16K
95.24%-4K
21.08%-292K
158.62%51K
-65.26%-157K
-4.08%-102K
6.67%-84K
-252.26%-370K
-210.13%-87K
Change In working capital
-55.87%522K
193.55%1.91M
29.39%-1.54M
-129.33%-1.59M
-37.39%1.45M
254.84%1.18M
-198.94%-2.05M
-219.78%-2.17M
1,055.46%5.43M
72.11%2.31M
-Change in prepaid assets
82.18%-162K
105.86%79K
1,927.22%3.09M
-255.19%-2.67M
74.90%-247K
-1,682.35%-909K
-307.54%-1.35M
-108.02%-169K
194.20%1.72M
-368.12%-984K
-Change in payables and accrued expense
-67.21%684K
295.63%1.84M
-130.57%-4.62M
-70.67%841K
-30.84%1.7M
392.57%2.09M
-166.15%-938K
-584.30%-2.01M
267.86%2.87M
739.32%2.46M
-Change in other current liabilities
----
----
----
-71.21%241K
----
----
----
----
-71.81%837K
----
-Change in other working capital
----
----
----
----
----
--6K
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
-17.70%-19.82M
-1,045.31%-18.3M
-12.86%-18.27M
7.86%-51.28M
-37.87%-16.66M
-7.54%-16.84M
87.61%-1.6M
-7.81%-16.18M
12.71%-55.66M
21.14%-12.09M
Investing cash flow
Cash flow from continuing investing activities
-29.74%12.03M
372.92%10.99M
9.74%28.71M
205.55%53.35M
399.23%7.74M
150.89%17.12M
103.63%2.32M
-47.29%26.17M
-3,594.81%-50.55M
-111.14%-2.59M
Net PPE purchase and sale
-92.86%2K
575.00%19K
99.33%-4K
58.00%-404K
184.26%166K
163.64%28K
99.29%-4K
-280.77%-594K
87.95%-962K
87.97%-197K
Net investment purchase and sale
-29.64%12.03M
371.29%10.97M
7.32%28.72M
208.42%53.76M
416.94%7.58M
150.87%17.09M
103.67%2.33M
-46.27%26.76M
-849.44%-49.58M
-109.62%-2.39M
Cash from discontinued investing activities
Investing cash flow
-29.74%12.03M
372.92%10.99M
9.74%28.71M
205.55%53.35M
399.23%7.74M
150.89%17.12M
103.63%2.32M
-47.29%26.17M
-3,594.81%-50.55M
-111.14%-2.59M
Financing cash flow
Cash flow from continuing financing activities
0
-26.95%103K
10K
-99.12%313K
-40.28%172K
0
-93.38%141K
0
3,613.67%35.58M
-47.45%288K
Net common stock issuance
----
----
----
--0
--0
--0
----
----
--35.12M
--0
Proceeds from stock option exercised by employees
--0
-26.95%103K
--10K
-31.36%313K
-40.28%172K
--0
34.29%141K
--0
-52.40%456K
-47.45%288K
Cash from discontinued financing activities
Financing cash flow
--0
-26.95%103K
--10K
-99.12%313K
-40.28%172K
--0
-93.38%141K
--0
3,613.67%35.58M
-47.45%288K
Net cash flow
Beginning cash position
-10.58%44.13M
5.91%51.34M
6.09%40.88M
-64.69%38.53M
-6.14%49.63M
-28.51%49.35M
-66.28%48.48M
-64.69%38.53M
-37.03%109.12M
-47.47%52.88M
Current changes in cash
-2,882.86%-7.79M
-932.91%-7.21M
4.77%10.46M
103.37%2.38M
39.21%-8.75M
101.73%280K
101.16%866K
-71.19%9.98M
-10.06%-70.63M
-270.30%-14.39M
Effect of exchange rate changes
-50.00%2K
-116.67%-1K
120.59%7K
-202.94%-35K
-132.35%-11K
--4K
--6K
---34K
--34K
--34K
End cash Position
-26.79%36.34M
-10.58%44.13M
5.91%51.34M
6.09%40.88M
6.09%40.88M
-6.14%49.63M
-28.51%49.35M
-66.28%48.48M
-64.69%38.53M
-64.69%38.53M
Free cash flow
-17.69%-19.82M
-1,043.13%-18.31M
-8.89%-18.27M
8.27%-51.94M
-36.11%-16.72M
-7.24%-16.84M
88.10%-1.6M
-10.61%-16.78M
21.08%-56.62M
27.59%-12.28M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -17.70%-19.82M-1,045.31%-18.3M-12.86%-18.27M7.86%-51.28M-37.87%-16.66M-7.54%-16.84M87.61%-1.6M-7.81%-16.18M12.71%-55.66M21.14%-12.09M
Net income from continuing operations -9.53%-21.06M-1,648.56%-21.21M-14.18%-17.44M14.87%-58.71M-45.98%-23M-15.54%-19.23M93.04%-1.21M20.17%-15.27M5.94%-68.96M18.55%-15.76M
Operating gains losses ---1K--34K--4K--4.67M--4.67M--------------------
Depreciation and amortization -91.64%31K-91.40%32K-89.78%37K-8.99%1.14M-89.14%39K3.63%371K0.81%372K111.70%362K299.05%1.26M378.67%359K
Other non cash items 98.73%-2K84.31%-16K95.24%-4K21.08%-292K158.62%51K-65.26%-157K-4.08%-102K6.67%-84K-252.26%-370K-210.13%-87K
Change In working capital -55.87%522K193.55%1.91M29.39%-1.54M-129.33%-1.59M-37.39%1.45M254.84%1.18M-198.94%-2.05M-219.78%-2.17M1,055.46%5.43M72.11%2.31M
-Change in prepaid assets 82.18%-162K105.86%79K1,927.22%3.09M-255.19%-2.67M74.90%-247K-1,682.35%-909K-307.54%-1.35M-108.02%-169K194.20%1.72M-368.12%-984K
-Change in payables and accrued expense -67.21%684K295.63%1.84M-130.57%-4.62M-70.67%841K-30.84%1.7M392.57%2.09M-166.15%-938K-584.30%-2.01M267.86%2.87M739.32%2.46M
-Change in other current liabilities -------------71.21%241K-----------------71.81%837K----
-Change in other working capital ----------------------6K----------------
Cash from discontinued investing activities
Operating cash flow -17.70%-19.82M-1,045.31%-18.3M-12.86%-18.27M7.86%-51.28M-37.87%-16.66M-7.54%-16.84M87.61%-1.6M-7.81%-16.18M12.71%-55.66M21.14%-12.09M
Investing cash flow
Cash flow from continuing investing activities -29.74%12.03M372.92%10.99M9.74%28.71M205.55%53.35M399.23%7.74M150.89%17.12M103.63%2.32M-47.29%26.17M-3,594.81%-50.55M-111.14%-2.59M
Net PPE purchase and sale -92.86%2K575.00%19K99.33%-4K58.00%-404K184.26%166K163.64%28K99.29%-4K-280.77%-594K87.95%-962K87.97%-197K
Net investment purchase and sale -29.64%12.03M371.29%10.97M7.32%28.72M208.42%53.76M416.94%7.58M150.87%17.09M103.67%2.33M-46.27%26.76M-849.44%-49.58M-109.62%-2.39M
Cash from discontinued investing activities
Investing cash flow -29.74%12.03M372.92%10.99M9.74%28.71M205.55%53.35M399.23%7.74M150.89%17.12M103.63%2.32M-47.29%26.17M-3,594.81%-50.55M-111.14%-2.59M
Financing cash flow
Cash flow from continuing financing activities 0-26.95%103K10K-99.12%313K-40.28%172K0-93.38%141K03,613.67%35.58M-47.45%288K
Net common stock issuance --------------0--0--0----------35.12M--0
Proceeds from stock option exercised by employees --0-26.95%103K--10K-31.36%313K-40.28%172K--034.29%141K--0-52.40%456K-47.45%288K
Cash from discontinued financing activities
Financing cash flow --0-26.95%103K--10K-99.12%313K-40.28%172K--0-93.38%141K--03,613.67%35.58M-47.45%288K
Net cash flow
Beginning cash position -10.58%44.13M5.91%51.34M6.09%40.88M-64.69%38.53M-6.14%49.63M-28.51%49.35M-66.28%48.48M-64.69%38.53M-37.03%109.12M-47.47%52.88M
Current changes in cash -2,882.86%-7.79M-932.91%-7.21M4.77%10.46M103.37%2.38M39.21%-8.75M101.73%280K101.16%866K-71.19%9.98M-10.06%-70.63M-270.30%-14.39M
Effect of exchange rate changes -50.00%2K-116.67%-1K120.59%7K-202.94%-35K-132.35%-11K--4K--6K---34K--34K--34K
End cash Position -26.79%36.34M-10.58%44.13M5.91%51.34M6.09%40.88M6.09%40.88M-6.14%49.63M-28.51%49.35M-66.28%48.48M-64.69%38.53M-64.69%38.53M
Free cash flow -17.69%-19.82M-1,043.13%-18.31M-8.89%-18.27M8.27%-51.94M-36.11%-16.72M-7.24%-16.84M88.10%-1.6M-10.61%-16.78M21.08%-56.62M27.59%-12.28M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More